Strengthening Pharmacovigilance in Latin America: Multidisciplinary Insights from Two ISoP Latin American Chapter Symposia
-
By
-
March 21, 2026
Objective:
To strengthen pharmacovigilance in Latin America through regional collaboration and multidisciplinary discussions, addressing specific regional challenges.
Key Findings:
- Regulatory convergence and integration of real-world evidence and AI are critical for enhancing pharmacovigilance.
- Monitoring of biosimilars and prevention of medication errors through a Human Factor/Ergonomics approach are essential.
- Expanding pharmacovigilance education, promoting patient engagement, and incorporating emerging areas such as pharmacogenomics are necessary for advancing drug safety.
Interpretation:
The discussions highlighted the need for a coordinated approach to pharmacovigilance in Latin America, addressing systemic challenges and opportunities for innovation.
Limitations:
- Heterogeneity in regulatory frameworks and resource availability across Latin American countries affects the implementation of pharmacovigilance.
- Differences in perspectives on implementation timelines and feasibility of advanced technologies hinder progress.
Conclusion:
The symposia provided a platform for sharing experiences and proposing strategies to strengthen pharmacovigilance, emphasizing the importance of regional collaboration, education, and addressing systemic challenges.
